871 results on '"Edelman, Martin J."'
Search Results
2. S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
3. American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy
4. Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society
5. “Cancer’s a demon”: a qualitative study of fear and multilevel factors contributing to cancer treatment delays
6. Targeted Therapies in Non-small Cell Lung Cancer
7. Benchmarks for Academic Oncology Faculty.
8. SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
9. Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)
10. Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
11. Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology
12. American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung Cancer
13. Targeted Therapies in Non-small Cell Lung Cancer
14. American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020
15. American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC
16. Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non–small cell lung cancer
17. Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic
18. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non–small-cell Lung Cancer Treated With Curative Intent
19. Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patients
20. Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation
21. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non–small-cell Lung Cancer at Diagnosis
22. 50 Years of progress in the systemic therapy of non-small cell lung cancer.
23. “Cancer’s a demon”: a qualitative study of fear and multilevel factors contributing to cancer treatment delays
24. Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing
25. Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622)
26. Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non–Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)
27. Chemotherapy Outcomes by Histologic Subtypes of Non-Small-Cell Lung Cancer: Analysis of the Southwest Oncology Group Database for Antimicrotubule-Platinum Therapy
28. Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
29. Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer Treatment
30. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839
31. Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
32. Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)
33. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)
34. American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma
35. Abstract 3310: Extracellular vesicles budding from stromal macrophages in the blood of metastatic non-small cell lung cancer patients correlates with poor survival
36. Abstract 1797: Impact of estrogen depletion using an aromatase inhibitor (AI) on EGFR-mutated non-small cell lung cancer (NSCLC) in a murine model
37. Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC
38. Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system
39. Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
40. Differential Gene Expression in Erlotinib-Treated Fibroblasts
41. Supplementary Figure Legend from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy
42. Figures S1-S6 and Tables S1-S2 from Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy
43. Supplementary Figure 1 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy
44. Supplementary Figures S1-S3 from Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias
45. Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy
46. Supplementary Figure 1 from KML001 Cytotoxic Activity Is Associated with Its Binding to Telomeric Sequences and Telomere Erosion in Prostate Cancer Cells
47. Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer
48. Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer
49. Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data
50. Novel Targeted Agents and Radiopharmaceuticals in Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.